Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 184

The DOI matches its Crossref record.

Randomized Evaluation of Polytetrafluoroethylene-Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial

Open access
Stankovic, Goran, Colombo, Antonio, Presbitero, Patrizia, van den Branden, Frank, Inglese, Luigi, Cernigliaro, Carmelo, Niccoli, Luigi, Bartorelli, Antonio L., Rubartelli, Paolo, Reifart, Nicholaus, Heyndrickx, Guy R., Saunamäki, Kari, Morice, Marie Claude, Sgura, Fabio A., Di Mario, Carlo · 2003 · Circulation

Abstract

Background— Treatment of lesions located in saphenous vein grafts (SVGs) is associated with increased procedural risk and a high rate of restenosis. Methods and Results— We conducted a randomized, multicenter trial to evaluate the usefulness of a polytetrafluoroethylene (PTFE)-covered stent compared with a bare stainless steel (SS) stent for prevention of restenosis and major adverse cardiac events (MACE) in patients undergoing SVG treatment. The primary end point was angiographic restenosis at 6 months. Secondary end points were 30-day and 6-month MACE rates, defined as the cumulative of death, myocardial infarction (MI), and target lesion revascularization. Between September 1999 and January 2002, 301 patients with SVG lesions were randomized to either the PTFE-covered JoStent coronary stent graft (PTFE group, n=156) or the SS JoFlex stent (control group, n=145). Angiographic and procedural success rates were similar between the 2 groups (97.4% versus 97.9% and 87.3% versus 93.8%, respectively). The incidence of 30-day MACE was higher in the PTFE group (10.9% versus 4.1%, P =0.047) and was mainly attributed to MI (10.3% versus 3.4%, P =0.037). The primary end point, the restenosis rate at 6-month follow-up, was similar between the 2 groups (24.2% versus 24.8%, P =0.237). Although the 6-month non–Q-wave MI rate was higher in the PTFE group (12.8% versus 4.1%, P =0.013), the cumulative MACE rate was not different (23.1% versus 15.9%, P =0.153). Conclusions— The study did not demonstrate a difference in restenosis rate and 6-month clinical outcome between the PTFE-covered stent and the SS stent for treatment of SVG lesions. However, a higher incidence of nonfatal myocardial infarctions was found in patients treated with the PTFE-covered stent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000079106.71097.1c

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 184

Metadata

Authors
Stankovic, G., Colombo, A., Presbitero, P., van den Branden, F., Inglese, L., Cernigliaro, C., Niccoli, L., Bartorelli, A. L., Rubartelli, P., Reifart, N., Heyndrickx, G. R., Saunamäki, K., Morice, M. C., Sgura, F. A., & Di Mario, C.
Venue
Circulation
Published
2003-07-08
Volume
108
Issue
1
Pages
37-42
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2108419122
Cited by
184
References
0
FWCI
11.28
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized Evaluation of Polytetrafluoroethylene-Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. https://app.cochat.ai/papers/10.1161/01.cir.0000079106.71097.1c
The paper
Stankovic, G., Colombo, A., Presbitero, P., van den Branden, F., Inglese, L., Cernigliaro, C., Niccoli, L., Bartorelli, A. L., Rubartelli, P., Reifart, N., Heyndrickx, G. R., Saunamäki, K., Morice, M. C., Sgura, F. A., & Di Mario, C. (2003). Randomized Evaluation of Polytetrafluoroethylene-Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Circulation. https://doi.org/10.1161/01.cir.0000079106.71097.1c

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.